Spike protein of SARS-CoV-2 variants: a brief review and practical implications

Braz J Microbiol. 2022 Sep;53(3):1133-1157. doi: 10.1007/s42770-022-00743-z. Epub 2022 Apr 9.

Abstract

The scientific community has been alarmed by the possible immunological evasion, higher infectivity, and severity of disease caused by the newest variants of SARS-CoV-2. The spike protein has an important role in the cellular invasion of viruses and is the target of several vaccines and therapeutic resources, such as monoclonal antibodies. In addition, some of the most relevant mutations in the different variants are on the spike (S) protein gene sequence that leads to structural alterations in the predicted protein, thus causing concern about the protection mediated by vaccines against these new strains. The present review highlights the most recent knowledge about COVID-19 and vaccines, emphasizing the different spike protein structures of SARS-CoV-2 and updating the reader about the emerging viral variants and their classifications, the more common viral mutations described and their distribution in Brazil. It also compiles a table with the most recent knowledge about all of the Omicron spike mutations.

Keywords: Brazil; COVID-19; Public health; SARS-CoV-2; Variants; Viral diseases.

Publication types

  • Review

MeSH terms

  • Antibodies, Neutralizing
  • Antibodies, Viral
  • COVID-19
  • Humans
  • Mutation
  • SARS-CoV-2* / genetics
  • Spike Glycoprotein, Coronavirus / genetics*
  • Viral Envelope Proteins / genetics

Substances

  • Antibodies, Neutralizing
  • Antibodies, Viral
  • Spike Glycoprotein, Coronavirus
  • Viral Envelope Proteins
  • spike protein, SARS-CoV-2

Supplementary concepts

  • SARS-CoV-2 variants